INO Other | INOVIO PHARMACEUTICALS, INC.

INOVIO PHARMACEUTICALS, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2024-03-06: Form 10-K; Item Stock registered under Section 12(b); As filed COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market.
2023-11-09: Form 10-Q; Item Stock registered under Section 12(b); As filed COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market.
2023-08-09: Form 10-Q; Item Stock registered under Section 12(b); As filed COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market.
2023-05-10: Form 10-Q; Item Stock registered under Section 12(b); As filed COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market.

Filed	Form	Item	As filed
2024-03-06	10-K	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2023-11-09	10-Q	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2023-08-09	10-Q	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2023-05-10	10-Q	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2023-03-01	10-K	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2022-11-08	10-Q	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2022-08-09	10-Q	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2022-05-10	10-Q	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2022-05-10	10-Q	Smaller reporting company	No
2022-03-01	10-K	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2022-03-01	10-K	Smaller reporting company	No
2022-03-01	10-K	Well-known seasoned issuer	Yes
2021-11-09	10-Q	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2021-11-09	10-Q	Smaller reporting company	No
2021-08-09	10-Q	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2021-08-09	10-Q	Smaller reporting company	No
2021-05-10	10-Q	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2021-05-10	10-Q	Smaller reporting company	No
2021-03-01	10-K	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2021-03-01	10-K	Smaller reporting company	No
2021-03-01	10-K	Well-known seasoned issuer	Yes
2020-11-09	10-Q	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2020-11-09	10-Q	Smaller reporting company	No
2020-08-10	10-Q	Stock registered under Section 12(b)	COMMON STOCK, $0.001 PAR VALUE · INO · Nasdaq Global Select Market
2020-08-10	10-Q	Smaller reporting company	No
2020-05-11	10-Q	Smaller reporting company	No
2020-03-12	10-K	Smaller reporting company	No
2019-11-12	10-Q	Smaller reporting company	No
2019-08-08	10-Q	Smaller reporting company	No
2019-05-09	10-Q	Smaller reporting company	No
2019-03-12	10-K	Smaller reporting company	No
2018-11-08	10-Q	Smaller reporting company	No

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
IMMUNIC, INC. (IMUX)	United States	$0.127B	-1.88
Aardvark Therapeutics, Inc. (AARD)	United States	$0.121B	-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)	United States	$0.121B	-8.95
Coya Therapeutics, Inc. (COYA)	United States	$0.121B	-6.35
MEDICINOVA INC (MNOV)	United States	$0.130B	-6.04
NRX Pharmaceuticals, Inc. (NRXP)	United States	$0.131B	-6.31
OnKure Therapeutics, Inc. (OKUR)	United States	$0.119B	-3.13
Unicycive Therapeutics, Inc. (UNCY)	United States	$0.134B	-3.70
TuHURA Biosciences, Inc./NV (HURA)	United States	$0.134B	-4.88
Immuneering Corp (IMRX)	United States	$0.113B	-12.51